INTRODUCTION
Liver cirrhosis can be described as a disease in which there is an imbalance between vasoconstrictor and vasodilator substances [l-31. Thus, a reduced response to most endogenous vasoconstrictors has been found in several cirrhotic experimental models [4-141. As plasma levels of noradrenaline, vasopressin and other vasoactive substances are usually elevated in cirrhosis, it is possible that an excess of local or systemic vasodilators is involved in the attenuation of their vasoconstrictor effects. The mechanisms mediating this phenomenon of pressor hyporesponsiveness in cirrhosis are not completely established.
Nitric oxide (NO) is a potent endogenous vasodilator that participates in the control of vascular tone, among other functions. NO is normally synthesized in vascular endothelium by a constitutive NO synthase, and its production can be induced in vascular smooth muscle and phagocytic cells in the presence of endotoxaemia and high levels of cytokines [3] . Recent studies point to an enhanced production of NO as one of the important pathogenetic mechanisms of the systemic and renal alterations present in liver cirrhosis [3, 151. However, there are conflicting reports regarding the role of NO in the vascular response to vasoconstrictors in different vascular beds. This is especially important in the frequently used rat model of bile duct ligation (BDL) [5, [13] [14] 161 . Thus, in the present study, we evaluated the vascular response of aortic rings from rats with chronic biliary cirrhosis to the a-adrenergic vasoconstrictor agent phenylephrine (PE) and the endothelium-dependent vasodilator acetylcholine (ACh) in order to assess the modulatory role of vascular endothelium. As NO is the major endothelium-derived vasodilating factor, we also analysed its participation by studying the involvement of the main NO synthase isoforms, constitutive and inducible, in the mediation of these vascular responses.
METHODS
All the experiments were performed according to the guidelines for the ethical treatment of the animals of the European Union. Male SpragueDawley rats born and raised in the Animal House of the University of Murcia were used in this study.
Bile duct ligation
Rats weighing initially 150-200 g were anaesthetized with ethylic ether and, under aseptic conditions, a double ligature and section of the common bile duct or a sham operation were performed, as previously described [17] . After closure of the abdominal wound, the animals were returned to their home cages, where they had complete access to normal rat chow and tap water. Biliary cirrhosis was diagnosed by clinical inspection (jaundice and coluria) and then confirmed post mortem.
Experimental protocol
Four weeks ( + 2 days) after BDL or sham operation, the animals were killed by retrocervical dislocation. After opening the thorax, the thoracic aorta was dissected, removed and placed in a Petri dish containing a Krebs-bicarbonate solution (in mmol/l: NaCl, 128; KCI, 4.7; MgC12-6H20, 1.2; H2KP04, 1.2; CaC12.2Hz0, 2.5; EDTA, 0.01; glucose, 11.1; NaHC03, 24). The aortas were carefully cleaned and cut into 3-mm rings. The rings were mounted horizontally between two stainless-steel hooks in individual organ bath chambers (5 ml) filled with Krebs solution and bubbled with 95% oxygen-5% carbon dioxide and maintained at 37°C and pH 7.4 throughout the experiment. The superior hook was connected to an isometric transducer (Pioden UF-1, Panlab, Barcelona, Spain) to measure changes in tension, which were amplified and recorded on a computer (Cibertec, Madrid, Spain). The rings were equilibrated for 60 min, changing the Krebs every 15 min, at an optimum resting tension of 2g. A cumulative concentration-response curve for PE (lop9 to mol/l) was then obtained. After finishing this curve, rings were repeatedly washed with Krebs and a 60-min period was observed. The rings were then again constricted with a maximum PE dose and a cumulative concentration-response curve for ACh (10W9 to 10-4 mol/l) was obtained.
Experimental groups
Four different groups of control and cirrhotic rings were studied: endothelium-intact rings under basal conditions (E+) or after preincubation with the NO synthesis inhibitors N-w-nitro-L-arginine methyl ester (L-NAME) or aminoguanidine (AG), and endothelium-denuded rings (E-). A total of 26 rats, 14 cirrhotic and 12 controls, were used. Usually each aorta was cut into 6-8 rings. In the endothelium-denuded groups, the endothelium was gently removed with a small, round, wooden stick with a smooth surface. After determining the ACh concentration-response curve in the endotheliumremoved rings, sodium nitroprusside (lop6 to mol/l) was added to confirm that endothelium removal did not affect the ability of aortic smooth muscle to relax. The nitric oxide synthesis inhibitors L-NAME and AG (both at mol/l) were added 15 min before starting to determine the contractionrelaxation curves. All drugs were purchased from Sigma (Madrid, Spain). Concentrations are expressed as final molar concentration in the organ chambers.
Statistical analysis
The contractile response to PE is expressed in grams with respect to a basal value of 2 g. The relaxation responses to ACh are expressed as a percentage of the contraction obtained with PE. Results are expressed as the means$-SEM. Statistical analysis was performed by two-way repeatedmeasures analysis of variance (ANOVA) and post hoc Duncan test where appropriate. The EDso values were calculated by regression analysis for every ring individually, and the differences between groups were analysed by Student's t-test. Differences were considered statistically significant at P < 0.05.
RESULTS
Examination of the BDL rats showed the typical characteristics of secondary biliary cirrhosis, including enlarged liver and spleen, portosystemic shunts, mesenteric oedema and ascites to a variable degree. There were no significant changes in control rats. Body weight was 327.0k18.0 g and 361.5+ 24.9 g for cirrhotic and control rats respectively.
Constrictor responses (Fig. I) The contractile response to PE was significantly lower in cirrhotic than in control aortic rings. The addition of L-NAME significantly increased and shifted to the left the responses to PE in both groups, so that the hyporesponsiveness to PE was eliminated. Similarly, removal of the endothelium induced a significant increase in the response to PE in cirrhotic and control rings. However, the pressor 
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PHENYLEPHRINE (-logM) Fig . I. Constrictor responses to PE in aortic rings from control and cirrhotic (BDL) rats. E-, rings without endothelium; L-NAME, rings pretreated with the NO synthesis inhibitor L-NAME AG, rings pretreated with AG.
hyporesponsiveness of the cirrhotic rings to PE was not completely eliminated after de-endothelization. In contrast, pretreatment with AG slightly potentiated the responses of both groups, but the lower response of the cirrhotic rings to PE was still evident. There were no differences between groups in EDso values in any experimental condition (Table  1) . However, L-NAME pretreatment and removal of the endothelium significantly decreased the EDso in both groups compared with the basal condition. In contrast, after AG administration, EDSO was significantly increased in the control group. Dilator responses (Fig. 2) In the basal situation, ACh induced a similar relaxation in both groups of rings and there were no differences between control and cirrhotic rings. The relaxation in response to ACh was eliminated in the presence of L-NAME and after removal of the endothelium in both control and BDL rings. However, AG administration did not modify the relaxation responses to ACh in any group. The EDso for ACh responses was significantly lower in intact rings from BDL rats than in rings from control rats and was not modified in the AG-pretreated rings (Table 2) . Endothelium removal did not alter the response of the smooth muscle in any group, as sodium nitroprusside relaxed in a similar way both cirrhotic and control denuded rings and there were no differences between them (control: loW6, 100. PE. E-, rings without endothelium; L-NAME, rings pretreated with the NO synthesis inhibitor L-NAME; AG, rings pretreated with AG. an increase in NO production might be largely responsible for this vascular alteration. Thus, different authors have shown that NO synthesis inhibition increases, and in some cases completely corrects, the poor vasoconstrictor responses of cirrhotic and portal hypertensive rats [6-8, 11, 141. However, in some cases, a role for NO could not be demonstrated [9, 13, 161. Specifically, the role of endothelium and NO in the modulation of the vasoconstrictor and vasodilator responses in aortas from chronic BDL rats has not been studied. In the 13] , is different. The present results clearly indicate that the reduced vascular responsiveness to PE exhibited by aortic rings from cirrhotic rats is due to the enhanced vasodilatory influence of NO, mainly of endothelial origin. The endothelium releases several vasodilatory compounds, and our results indicate that synthesis inhibition of one of them, NO, results in correction of the reduced vasoconstrictor response of the cirrhotic aortic rings. This clearly indicates that an enhanced NO activity is mainly responsible for this vascular hyporesponsiveness. However, one might imagine that this excess of NO in response to the vasoconstrictor adrenergic agonist would also be present when challenging the vessel with ACh, an endothelium-dependent vasodilator. However, this was not the case, and the vasodilator response to ACh was unaltered in the cirrhotic rings compared with that of the controls, although the ED50 was lower in the cirrhotic rats, indicative of a somewhat greater sensitivity. Overall, this result would suggest that not all NO release mechanisms are altered in this cirrhotic model. As already mentioned, similar results have recently been published [13] in the same cirrhotic model. However, we and other authors have found that ACh produces greater relaxations in vessels from carbon tetrachloridetreated cirrhotic rats [ l l , 121, supporting different roles for NO and different pathophysiological mechanisms depending on the experimental model studied.
As already mentioned, some studies [3, 7, 81 suggest the existence of a systemic activation of the constitutive endothelial NO synthase as the main isoform responsible for the enhanced activity of NO in cirrhosis. However, we found that removal of the endothelium did not completely correct the hyporesponsiveness to PE, which may be indicative of the existence of a muscular vasodilatory mechanism that also contributes to this vascular alteration. As L-NAME corrected the hyporesponsiveness to PE of the cirrhotic rings, we hypothesized that a muscular NO synthase could also be involved in the vascular hyporesponsiveness of cirrhotic rings.
It has been reported that the inducible isoform of NO synthase can be found in smooth muscle cells, as well as in endothelium [18, 191 . Moreover, cirrhosis is a disease in which there are elevated levels of endotoxaemia and cytokines, both known stimuli for the inducible NOS. At the dose used in the present study, AG has been identified as a selective inhibitor of this isoform , and our results show that AG did not significantly affect the response to ACh, indicating that the constitutive endothelial NO synthase isoform was not altered at this dose. However, the pressor response to PE was not modified by pretreatment with AG, and the rings from the cirrhotic animals still exhibited a reduced pressor response. Other factors, including cyclo-oxygenase-derived products or smooth muscle alteration, may be involved in the residual hyporesponsiveness shown by the endotheliumdenuded cirrhotic rings. Overall, the present results suggest that the hyporesponsiveness of the cirrhotic aortic rings is not due to activation of the inducible NO enzyme and point to the constitutive isoform, mostly of endothelial origin, as the main factor responsible for this vascular alteration.
In the present study, pretreatment of the aortic rings with an NO inhibitor or endothelium removal decreased the ED50 to phenylephrine in both groups, which indicates the important role played by NO in particular, and the endothelium in general, as a mechanism that counteracts the action of vasoconstrictors. This has been also previously shown in different types of vessels [24, 251. It is now clear that NO can be released by several mechanisms [26] . One way is that used by endothelium-dependent vasodilators, such as ACh, which increase NO production as a result of the elevation in endothelial cell calcium levels brought about by agonist-mediated G-protein activation. As already mentioned, our results and those of Lee et al. [13] indicate that this pathway is not altered in the rat cirrhotic BDL model. Another mechanism is secondary to the binding of the vasoconstrictor, such as PE, to specific receptors in smooth muscle, a-adrenergic receptors in this case. In this situation, at least two mechanisms, the vasoconstrictioninducing stretching of the vessel wall or a shearstress related mechanism, could activate the release of endothelial NO. It is this mechanism that our data identifies as defective in cirrhosis.
In summary, aortic rings from cirrhotic BDL rats exhibit a reduced pressor response to PE that can be corrected by inhibition of NO synthesis. The NO synthase isoform involved is mainly of endothelial origin and is constitutively expressed. Finally, our results also indicate that the endothelium-dependent vasodilatation is normal in this model, and this suggests that not all the NO release mechanisms are altered.
